Sanofi prices €2.3 billion bond issue with maturities up to 2037 for general corporate use

Sanofi has successfully priced a €2.3 billion bond offering split into three tranches with maturities in 2029, 2033, and 2037, bearing fixed interest rates from 3.000% to 3.750%. The bonds are issued under Sanofi's Euro Medium Term Note program, with proceeds intended for general corporate purposes. This funding move supports Sanofi's ongoing operations and growth initiatives. The transaction was led by major global banks including Citigroup, HSBC, and J.P. Morgan.